The incidence risk of preeclampsia in pregnant women treated with selenium supplementation versus placebo
Phase 2
- Conditions
- Pre-eclampsia.Pre-eclampsia, unspecified
- Registration Number
- IRCT201702109014N143
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 158
Inclusion Criteria
Primigravid; first trimester.
Exclusion criteria: Using selenium supplementation during past year; using any medications except ferrous sulfate and folic acid; thyroid disease; diabetes; hypertension; infective diseases; diet full of selenium.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring systolic and diastolic blood pressure. Timepoint: before intervention and at the end of pregnancy. Method of measurement: through physical examination.
- Secondary Outcome Measures
Name Time Method